Summary of Study ST000014
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000013. The data can be accessed directly via it's Project DOI: 10.21228/M8G59C This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST000014 |
| Study Title | Skeletal Muscle Treatment (palmitate/palmitoyl carnitine) |
| Study Type | MS analysis |
| Study Summary | Isolated skelelal muscle mitochondria incubated in the presence of fatty acid oxidation precursors, palmitic acid and palmitoyl carnitine |
| Institute | University of California, Davis |
| Department | Davis Genome Center |
| Laboratory | Fiehn |
| Last Name | Kind |
| First Name | Tobias |
| Address | 451 E. Health Sci. Drive, Davis, California 95616, USA |
| tkind@ucdavis.edu | |
| Submit Date | 2013-05-20 |
| Num Groups | 12 |
| Total Subjects | 72 |
| Raw Data Available | No |
| Analysis Type Detail | GC-MS |
| Release Date | 2013-06-19 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR000013 |
| Project DOI: | doi: 10.21228/M8G59C |
| Project Title: | Skeletal Muscle Treatment |
| Project Type: | MS analysis |
| Institute: | University of California, Davis |
| Department: | Davis Genome Center |
| Laboratory: | Fiehn |
| Last Name: | Fiehn |
| First Name: | Oliver |
| Address: | 451 E. Health Sci. Drive, Davis, California 95616, USA |
| Email: | ofiehn@ucdavis.edu |
Subject:
| Subject ID: | SU000030 |
| Subject Type: | Animal |
| Subject Species: | Mus musculus |
| Taxonomy ID: | 10090 |
| Age Or Age Range: | 0.25 years |
| Gender: | male |
| Animal Animal Supplier: | University of Ottawa, Canada Mary-Ellen Harper PhD, PI; |
| Species Group: | Mammals |
Factors:
Subject type: Animal; Subject species: Mus musculus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Compartment | Minutes | Skeletal Muscle Treatment |
|---|---|---|---|---|
| SA000732 | 103879 | cytosol | 0 | palmitic acid 2.4 uM |
| SA000733 | 103884 | cytosol | 0 | palmitic acid 2.4 uM |
| SA000734 | 103889 | cytosol | 0 | palmitic acid 2.4 uM |
| SA000735 | 103894 | cytosol | 0 | palmitic acid 2.4 uM |
| SA000736 | 103899 | cytosol | 0 | palmitic acid 2.4 uM |
| SA000737 | 103904 | cytosol | 0 | palmitic acid 2.4 uM |
| SA000756 | 104003 | cytosol | 0 | palmitic acid 9.6 uM |
| SA000757 | 104008 | cytosol | 0 | palmitic acid 9.6 uM |
| SA000758 | 104013 | cytosol | 0 | palmitic acid 9.6 uM |
| SA000759 | 104018 | cytosol | 0 | palmitic acid 9.6 uM |
| SA000760 | 104023 | cytosol | 0 | palmitic acid 9.6 uM |
| SA000761 | 104028 | cytosol | 0 | palmitic acid 9.6 uM |
| SA000780 | 104127 | cytosol | 0 | palmitoyl carnitine 9.6 uM |
| SA000781 | 104132 | cytosol | 0 | palmitoyl carnitine 9.6 uM |
| SA000782 | 104137 | cytosol | 0 | palmitoyl carnitine 9.6 uM |
| SA000783 | 104142 | cytosol | 0 | palmitoyl carnitine 9.6 uM |
| SA000784 | 104147 | cytosol | 0 | palmitoyl carnitine 9.6 uM |
| SA000785 | 104152 | cytosol | 0 | palmitoyl carnitine 9.6 uM |
| SA000744 | 103941 | cytosol | 20 | palmitic acid 2.4 uM |
| SA000745 | 103946 | cytosol | 20 | palmitic acid 2.4 uM |
| SA000746 | 103951 | cytosol | 20 | palmitic acid 2.4 uM |
| SA000747 | 103956 | cytosol | 20 | palmitic acid 2.4 uM |
| SA000748 | 103961 | cytosol | 20 | palmitic acid 2.4 uM |
| SA000749 | 103966 | cytosol | 20 | palmitic acid 2.4 uM |
| SA000768 | 104065 | cytosol | 20 | palmitic acid 9.6 uM |
| SA000769 | 104070 | cytosol | 20 | palmitic acid 9.6 uM |
| SA000770 | 104075 | cytosol | 20 | palmitic acid 9.6 uM |
| SA000771 | 104080 | cytosol | 20 | palmitic acid 9.6 uM |
| SA000772 | 104085 | cytosol | 20 | palmitic acid 9.6 uM |
| SA000773 | 104090 | cytosol | 20 | palmitic acid 9.6 uM |
| SA000792 | 104189 | cytosol | 20 | palmitoyl carnitine 9.6 uM |
| SA000793 | 104194 | cytosol | 20 | palmitoyl carnitine 9.6 uM |
| SA000794 | 104199 | cytosol | 20 | palmitoyl carnitine 9.6 uM |
| SA000795 | 104204 | cytosol | 20 | palmitoyl carnitine 9.6 uM |
| SA000796 | 104209 | cytosol | 20 | palmitoyl carnitine 9.6 uM |
| SA000797 | 104214 | cytosol | 20 | palmitoyl carnitine 9.6 uM |
| SA000738 | 103910 | mito | 0 | palmitic acid 2.4 uM |
| SA000739 | 103915 | mito | 0 | palmitic acid 2.4 uM |
| SA000740 | 103920 | mito | 0 | palmitic acid 2.4 uM |
| SA000741 | 103925 | mito | 0 | palmitic acid 2.4 uM |
| SA000742 | 103930 | mito | 0 | palmitic acid 2.4 uM |
| SA000743 | 103935 | mito | 0 | palmitic acid 2.4 uM |
| SA000762 | 104034 | mito | 0 | palmitic acid 9.6 uM |
| SA000763 | 104039 | mito | 0 | palmitic acid 9.6 uM |
| SA000764 | 104044 | mito | 0 | palmitic acid 9.6 uM |
| SA000765 | 104049 | mito | 0 | palmitic acid 9.6 uM |
| SA000766 | 104054 | mito | 0 | palmitic acid 9.6 uM |
| SA000767 | 104059 | mito | 0 | palmitic acid 9.6 uM |
| SA000786 | 104158 | mito | 0 | palmitoyl carnitine 9.6 uM |
| SA000787 | 104163 | mito | 0 | palmitoyl carnitine 9.6 uM |
| SA000788 | 104168 | mito | 0 | palmitoyl carnitine 9.6 uM |
| SA000789 | 104173 | mito | 0 | palmitoyl carnitine 9.6 uM |
| SA000790 | 104178 | mito | 0 | palmitoyl carnitine 9.6 uM |
| SA000791 | 104183 | mito | 0 | palmitoyl carnitine 9.6 uM |
| SA000750 | 103972 | mito | 20 | palmitic acid 2.4 uM |
| SA000751 | 103977 | mito | 20 | palmitic acid 2.4 uM |
| SA000752 | 103982 | mito | 20 | palmitic acid 2.4 uM |
| SA000753 | 103987 | mito | 20 | palmitic acid 2.4 uM |
| SA000754 | 103992 | mito | 20 | palmitic acid 2.4 uM |
| SA000755 | 103997 | mito | 20 | palmitic acid 2.4 uM |
| SA000774 | 104096 | mito | 20 | palmitic acid 9.6 uM |
| SA000775 | 104101 | mito | 20 | palmitic acid 9.6 uM |
| SA000776 | 104106 | mito | 20 | palmitic acid 9.6 uM |
| SA000777 | 104111 | mito | 20 | palmitic acid 9.6 uM |
| SA000778 | 104116 | mito | 20 | palmitic acid 9.6 uM |
| SA000779 | 104121 | mito | 20 | palmitic acid 9.6 uM |
| SA000798 | 104220 | mito | 20 | palmitoyl carnitine 9.6 uM |
| SA000799 | 104225 | mito | 20 | palmitoyl carnitine 9.6 uM |
| SA000800 | 104230 | mito | 20 | palmitoyl carnitine 9.6 uM |
| SA000801 | 104235 | mito | 20 | palmitoyl carnitine 9.6 uM |
| SA000802 | 104240 | mito | 20 | palmitoyl carnitine 9.6 uM |
| SA000803 | 104245 | mito | 20 | palmitoyl carnitine 9.6 uM |
| Showing results 1 to 72 of 72 |
Collection:
| Collection ID: | CO000014 |
| Collection Summary: | - |
| Sample Type: | Tissue |
| Collection Method: | isolated skelelal muscle mitochondria incubated in the presence of fatty acid oxidation precursors. |
| Collection Time: | 9/4/06 |
| Volumeoramount Collected: | 1 mg |
Treatment:
| Treatment ID: | TR000022 |
| Treatment Compound: | palmitic acid 2.4 uM | palmitic acid 9.6 uM | palmitoyl carnitine 9.6 uM |
Sample Preparation:
| Sampleprep ID: | SP000027 |
| Sampleprep Summary: | - |
| Sampleprep Protocol ID: | Mitochondrial Matrix Preparation |
| Extraction Method: | Extramitochondrial Buffer Preparation: The Harper lab first entrifuged mitochondrial preparations in order to get the extramitochondrial buffer and mitochondrial pellet. Mitochondrial Matrix Preparation: the mitochondrial matrix was exposed by repeated freeze-thaws of the mitochondrial pellet; the insoluble material was spun down, and supernatant collected as matrix. Pellets were resuspended in 100 ul of buffer (140 mM KCL, 20 HEPES, 5 K2HPO4, 1 EGTA, pH 7.4 at RT) |
| Organ: | skeletal muscle |
| Organ Specification: | total |
| Cell Type: | myocyte |
| Subcellular Location: | extramitochondrial buffer |
Chromatography:
| Chromatography ID: | CH000014 |
| Instrument Name: | Agilent 6890N |
| Chromatography Type: | GC |
Analysis:
| Analysis ID: | AN000031 |
| Analysis Type: | MS |
| Instrument Name: | Leco Pegasus III GC-TOF |
| Chromatography ID: | CH000014 |
| Num Factors: | 12 |
| Num Metabolites: | 64 |
| Units: | Peak height |